A once-daily pill called sulthiame cut breathing interruptions during sleep by up to 47 percent in adults with obstructive ...

The company’s latest product brings vibe-coding to the data layer of enterprise data systems. AI coding agents have become ...

Two phase 2b studies in atopic dermatitis and alopecia areata reported positive outcomes, demonstrating clinically meaningful ...

Last week, 85 people filed into Alameda County Superior Court in downtown Oakland. They’d been called to serve as jurors for ...

In a recent video interview with Applied Clinical Trials, Marc Buyse, ScD, founder and CEO of IDDI, discussed how growing trial complexity is creating new challenges for data conf ...

Dead in Antares is a mysterious tale of survival with a team of experts stranded on a hostile alien exoplanet.

The American Journal of Preventive Cardiology (AJPC) announces the publication of the POLY-ACS trial investigating the effectiveness of a polypill strategy, combining multiple evidence-based therapies ...

December 31, 2025 to be further enhanced by $35 million expected from Medtronic and Ligand in Q2 2026 from previously announced transactions, as well as Haemonetics’ Vivasure acquisition proceeds$33.5 ...

December 31, 2025 to be further enhanced by $35 million expected from Medtronic and Ligand in Q2 2026 from previously announced transactions, as well as Haemonetics' ...

Barclays 28th Annual Global Healthcare Conference March 11, 2026 10:30 AM EDTCompany ParticipantsSanjiv Patel - ...

Dianthus Therapeutics Inc. DNTH shares are up during Monday’s premarket session following an early GO decision announced by the company based on an interim responder analysis in the Phase 3 CAPTIVATE ...